Aclarion, Inc. (ACON)
2.64
+0.09
(+3.53%)
USD |
NASDAQ |
Sep 17, 16:00
2.63
-0.01
(-0.38%)
Pre-Market: 20:00
Aclarion Enterprise Value : -9.810M for Sept. 17, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 17, 2026 | -9.810M |
| September 16, 2026 | -10.03M |
| September 15, 2026 | -9.860M |
| September 14, 2026 | -9.958M |
| September 11, 2026 | -9.909M |
| September 10, 2026 | -10.06M |
| September 09, 2026 | -10.35M |
| September 08, 2026 | -10.30M |
| September 04, 2026 | -10.52M |
| September 03, 2026 | -10.67M |
| September 02, 2026 | -10.62M |
| September 01, 2026 | -10.57M |
| August 31, 2026 | -10.52M |
| August 28, 2026 | -10.40M |
| August 27, 2026 | -10.11M |
| August 26, 2026 | -10.43M |
| August 25, 2026 | -10.18M |
| August 24, 2026 | -9.761M |
| August 21, 2026 | -9.638M |
| August 20, 2026 | -9.687M |
| August 19, 2026 | -9.490M |
| August 18, 2026 | -9.909M |
| August 17, 2026 | -9.490M |
| August 14, 2026 | -10.25M |
| August 13, 2026 | -10.40M |
| Date | Value |
|---|---|
| August 12, 2026 | -10.60M |
| August 11, 2026 | -10.70M |
| August 10, 2026 | -10.50M |
| August 07, 2026 | -10.67M |
| August 06, 2026 | -10.52M |
| August 05, 2026 | -10.50M |
| August 04, 2026 | -10.45M |
| August 03, 2026 | -10.50M |
| July 31, 2026 | -10.77M |
| July 30, 2026 | -11.34M |
| July 29, 2026 | -11.35M |
| July 28, 2026 | -11.07M |
| July 27, 2026 | -10.84M |
| July 24, 2026 | -10.35M |
| July 23, 2026 | -10.28M |
| July 22, 2026 | -10.03M |
| July 21, 2026 | -10.06M |
| July 20, 2026 | -9.835M |
| July 17, 2026 | -9.958M |
| July 16, 2026 | -9.810M |
| July 15, 2026 | -9.761M |
| July 14, 2026 | -9.736M |
| July 13, 2026 | -9.687M |
| July 10, 2026 | -9.308M |
| July 09, 2026 | -9.146M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Biotricity, Inc. | 32.36M |
| MedLink International, Inc. | -- |
| Agilent Technologies, Inc. | 46.27B |
| Abbott Laboratories | 204.55B |
| Align Technology, Inc. | 9.684B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.748M |
| Revenue (Quarterly) | 0.0252M |
| Total Expenses (Quarterly) | 2.773M |
| EPS Diluted (Quarterly) | -1.116 |
| Gross Profit Margin (Quarterly) | -212.7% |
| Profit Margin (Quarterly) | -10.90K% |
| Earnings Yield | -287.8% |
| Normalized Earnings Yield | -287.75 |